N-formyltryptophan: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 582651 |
SCHEMBL ID | 120495 |
MeSH ID | M0109103 |
Synonym |
---|
LS-14060 |
n-formyltryptophan |
16108-03-5 |
n-formyl-dl-tryptophan |
2-formamido-3-(1h-indol-3-yl)propanoic acid |
FT-0654303 |
F0134 |
nalpha-formyl-dl-tryptophan |
A810221 |
AKOS009158993 |
formyl-dl-trp-oh |
tryptophan, n-formyl- |
SCHEMBL120495 |
RNEMLJPSSOJRHX-UHFFFAOYSA-N |
n-formyltryptophan # |
n-formyl-dl-tryptophan 99+% |
mfcd00055983 |
n-formyl-dl-tryptophan, 98% (for-dl-trp-oh) |
DTXSID10936447 |
n-(hydroxymethylidene)tryptophan |
T71874 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.42) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |